Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 2 1Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Prostatic Neoplasms 54Lymphoma 44Lymphoma, Large B-Cell, Diffuse 35Lymphoma, Follicular 31Precursor Cell Lymphoblastic Leukemia-Lymphoma 22Lymphoma, Non-Hodgkin 22Multiple Myeloma 19Leukemia 17Burkitt Lymphoma 13Hodgkin Disease 12Lymphoma, Mantle-Cell 10Neoplasms 9Lymphoma, Large-Cell, Immunoblastic 8Lymphoma, B-Cell, Marginal Zone 8Lymphoma, Large-Cell, Anaplastic 7Neoplasms, Plasma Cell 6Neoplasm Metastasis 6Lymphoma, T-Cell, Peripheral 6Recurrence 4Leukemia, Lymphocytic, Chronic, B-Cell 4Parkinson Disease 4, Autosomal Dominant Lewy Body 3Pain 3Lymphoma, B-Cell 3Prostatic Neoplasms, Castration-Resistant 2Prostate Cancer Metastatic 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2Myasthenia Gravis 2Leukemia, Biphenotypic, Acute 2Disease 2

Interventions

pegaspargase 4Oxaliplatin 3Gemcitabine 3Methotrexate 2Etoposide 2Early Intervention, Educational 2Doxorubicin 2Dexamethasone 2sugemalimab 1ferrous sulfate 1ferric gluconate 1Vincristine 1Thalidomide 1Sucrose 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Psychiatric Rehabilitation 1Prednisone 1Pharmacogenomic Testing 1Ketamine 1Drug Therapy 1Darbepoetin alfa 1Cyclophosphamide 1Ciprofloxacin 1Asian ginseng 1Amoxicillin-Potassium Clavulanate Combination 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Lymphoma, Extranodal NK-T-Cell × Prednisone × Clear all
NCT02359162 2018-05-09

Efficacy and Safety Study of P-Gemox vs.EPOCH as First-line Chemotherapy to Treat NK/T-cell Lymphoma With Early Stage

Sun Yat-sen University

Phase 3 Terminated
50 enrolled
Lymphoid

Lymphoma, Extranodal NK-T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡